Hoffmann-La Roche: all 2,744 studies
Page 19 of 28. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.
- An Observational Study to Evaluate the Clinical Effectiveness, Quality of Life, Safety and Tolerability of Tocilizumab (TCZ) in Patients With Rheumatoid Arthritis (RA) in Daily Clinical PracticeCompletedNCT02552940
- Observational Study to Evaluate Disease Course and Outcomes in Patients Treated With Esbriet (Pirfenidone) for Idiopathic Pulmonary Fibrosis (IPF) in CanadaCompletedNCT02552849
- Study of Intravenous RXDX-107 in Patients With Solid TumorsTerminatedNCT02548390Phase 1
- A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home SettingWithdrawnNCT02546869Phase 3
- Avastin (Bevacizumab) in the Treatment of Metastatic Colorectal Cancer in Normal Clinical Use in the UK PopulationWithdrawnNCT02542436
- Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in KoreaCompletedNCT02538562
- Longitudinal Cohort Study in Participants With Severe Asthma to Assess BiomarkersCompletedNCT02537691Phase 4
- Ipatasertib (GDC-0068) Study to Evaluate Formulation Change and Food Effect on Bioavailability in Healthy SubjectsCompletedNCT02536391Phase 1
- A Phase IV Study to Evaluate the Effect of Subcutaneous (SC) Tocilizumab Administered to Participants With Rheumatoid Arthritis (RA) Assessed Using Disease Activity Score (DAS28)CompletedNCT02534311
- Basmisanil Positron Emission Tomography Study in Japanese VolunteersCompletedNCT02534207Phase 1
- A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MHAB5553A in Healthy VolunteersCompletedNCT02528903Phase 1
- A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral IbandronateCompletedNCT02528747
- A Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult ParticipantsCompletedNCT02525484Phase 1
- A Multiple Ascending-Dose Study of RG7625 in Healthy VolunteersCompletedNCT02521610Phase 1
- A Study of Atezolizumab Administered Alone or in Combination With Azacitidine in Participants With Myelodysplastic SyndromesCompletedNCT02508870Phase 1
- Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus RibavirinCompletedNCT02508090
- A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)CompletedNCT02500407Phase 1/2
- Effect of RO6871765 and RO7011785 on Immune Response With the Stimulation of Peripheral Blood Mononuclear Cells (PBMCs) in Chinese Healthy Volunteers and Chronic Hepatitis B PatientsTerminatedNCT02498275
- A Study Of Mircera In Patients With Kidney Disease Who Are Not On DialysisCompletedNCT02490514
- A Bioequivalence Study of Subcutaneous (SC) Lebrikizumab Administered by Needle and Syringe or by Prefilled Syringe With Needle Safety Device (PFS-NSD)CompletedNCT02486809Phase 1
- A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of AgeTerminatedNCT02484703Phase 2
- A Study of Disease Progression in Patients With Geographic Atrophy Secondary to Age-Related Macular DegenerationTerminatedNCT02479386
- Safety of Xeloda in Solid TumoursCompletedNCT02479217
- A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care TreatmentCompletedNCT02476942
- A Single Ascending Dose Study of PCO371 in Healthy VolunteersTerminatedNCT02475616Phase 1
- A Safety, Tolerability, and Pharmacokinetic Study of GDC-3280 in Healthy ParticipantsCompletedNCT02471859Phase 1
- A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid TumorsCompletedNCT02471846Phase 1
- A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RG1662 in Healthy SubjectsCompletedNCT02470832Phase 1
- Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical CancerCompletedNCT02467907Phase 2
- A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic DermatitisCompletedNCT02465606Phase 2
- Rituximab in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic LeukemiaCompletedNCT02461316
- Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in ChinaCompletedNCT02458651
- A Study of Escalating Doses of DCDS0780A in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's LymphomaCompletedNCT02453087Phase 1
- Long Term Extension Study is Designed to Monitor Long-Term Efficacy and Safety of Miravirsen Sodium in Combination With Telaprevir and Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1 InfectionCompletedNCT02452814
- Non-drug Study to Evaluate the Suitability of Neurocognitive Tests and Functioning Scales for the Measurement of Cognitive and Functioning Changes in Children With Down SyndromeCompletedNCT02451657
- Study of Anemia in Chronic Kidney Disease (CKD) Among High-Risk Hypertensive and Diabetic Patients in PakistanCompletedNCT02444845
- A Study to Determine the Safety and Tolerability of Herceptin as an Adjuvant Therapy of Early Breast CancerCompletedNCT02443467
- Bioavailability Study of Vemurafenib in Participants With BRAF^V600 Mutation-Positive MalignanciesCompletedNCT02441465Phase 1
- Observational Study of Vismodegib (Erivedge) in Patients Treated in ArgentinaCompletedNCT02438644
- A Study of the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Dose Basimglurant in Healthy Subjects and in Patients With Major Depressive Disorder (MDD)CompletedNCT02433093Phase 1
- A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)CompletedNCT02431208Phase 1
- Non-drug Study to Assess the Suitability of Assessment Scales in Japanese Individuals With Down Syndrome Aged 6-30CompletedNCT02431117
- A Study in Healthy Volunteers to Assess the Relative Bioavailability and Tolerability of Two Crenezumab Formulations Following Administration of a Single Subcutaneous DoseCompletedNCT02427243Phase 1
- Safety of Herceptin/Trastuzumab in Metastatic Breast CancerCompletedNCT02424682
- Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in PakistanCompletedNCT02422069
- Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®)CompletedNCT02420132
- A Study to Assess the Safety and Pharmacokinetics of MOXR0916 and Atezolizumab (Also Known as MPDL3280A or Anti-PD-L1) in Participants With Locally Advanced or Metastatic Solid TumorsCompletedNCT02410512Phase 1
- Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections to Reach HbA1c Targets in Children and Adolescents With Type 1 DiabetesCompletedNCT02403375Not applicable
- Phase IIIb Study to Evaluate the Safety and Tolerability of Herceptin SC With Perjeta and Docetaxel in Patients With HER2-positive Advanced Breast CancerCompletedNCT02402712Phase 3
- Non-Interventional Study of Tocilizumab Subcutaneous (SC) Monotherapy in Participants With Rheumatoid Arthritis (RA)CompletedNCT02402686
- A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular DegenerationTerminatedNCT02399072
- Human Epidermal Growth Factor Receptor 2 (HER2) Positive Unresectable Locally Advanced or Metastatic Breast Cancer Disease Registry StudyCompletedNCT02393924
- BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and OlderCompletedNCT02393898
- A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT02391805Phase 2
- A Phase I Bioavailability and Pharmacokinetic Study of [14C]-Ipatasertib Single Oral and Intravenous Doses in Healthy Male SubjectsCompletedNCT02390492Phase 1
- A Study to Assess the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Advanced Basal Cell Carcinoma (BCC)CompletedNCT02371967
- A Study of Crenezumab in Participants With Mild to Moderate Alzheimer DiseaseCompletedNCT02353598Phase 1
- A Study of Intravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid TumorsCompletedNCT02350673Phase 1
- A Study of the Effect of RG1662 on Metformin in Healthy VolunteersCompletedNCT02342925Phase 1
- A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic DermatitisCompletedNCT02340234Phase 2
- A Study Evaluating the Safety of Tocilizumab in Addition to Standard of Care Premedication Given Before Obinutuzumab + Chlorambucil in Participants With Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL) and ComorbiditiesTerminatedNCT02336048Phase 1
- A Study of RO6958688 in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen Positive Solid TumorsCompletedNCT02324257Phase 1
- A Study of Emactuzumab and Atezolizumab Administered in Combination in Participants With Advanced Solid TumorsCompletedNCT02323191Phase 1
- Observational Safety Study of Rituximab in Patients Diagnosed With Rheumatoid Arthritis (RA) Who Did Not Respond Adequately to TNF-alpha BlockerCompletedNCT02322801
- A Study to Investigate the Safety, Tolerability and Pharmacokinetics of RO6889678 and the Combination of RO6889678 With Ritonavir in Healthy ParticipantsTerminatedNCT02321384Phase 1
- A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical TrialActive, not recruitingNCT02320435Phase 3
- A Study of RO6927005 Either As Monotherapy (Part A) or in Combination With Gemcitabine and Nab-Paclitaxel (Part B) to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Activity in Patients With Mesothelin-positive Metastatic and/or Locally Advanced Malignant Solid TumorsTerminatedNCT02317419Phase 1
- A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast CancerCompletedNCT02316509Phase 1
- A Study of RO6870810/TEN-010 in Participants With Acute Myeloid Leukemia and Myelodysplastic SyndromeCompletedNCT02308761Phase 1
- An Observational Study of Kadcyla Safety in Breast CancerCompletedNCT02305641
- An Observational Study of Herceptin SC Safety in Breast CancerCompletedNCT02305628
- An Observational Study of Continued Bevacizumab Plus Chemotherapy Until First Progression in Participants With Metastatic Colorectal Cancer (CRC)CompletedNCT02305615
- A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid TumorsCompletedNCT02304393Phase 1
- A Study of RG7625 in Healthy VolunteersCompletedNCT02295332Phase 1
- An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer: Continued Avastin Plus Chemotherapy After First Progression in Clinical PracticeCompletedNCT02287597
- An Observational Study of the Safety of Herceptin Given Subcutaneously in Patients With Early HER2-positive Breast CancerCompletedNCT02286362
- A Study of High Dose MHAA4549A in Healthy VolunteersCompletedNCT02284607Phase 1
- A Study of RO6926496 in Healthy VolunteersCompletedNCT02281786Phase 1
- Non-Interventional Study of Xeloda (Capecitabine) in Patients With Gastric CancerCompletedNCT02274376
- Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor TherapyNo longer availableNCT02271139
- A German Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Type 2 Diabetes Patients.CompletedNCT02268929Not applicable
- Observational Study of Pertuzumab Safety in Participants With Breast CancerCompletedNCT02266173
- A Study of RO5186582 Treatment on Cytochrome P450 (CYP) 3A4 Activity in Healthy ParticipantsCompletedNCT02254759Phase 1
- Study of Tocilizumab (RoActemre) Administered Subcutaneously in Participants With Rheumatoid Arthritis in Everyday Clinical PracticeCompletedNCT02251860
- A Study of RO6885247 in Adult and Pediatric Patients With Spinal Muscular Atrophy (MOONFISH)TerminatedNCT02240355Phase 1
- An Observational Study of Patients With Malignant Lymphomas Treated With MabThera® SC in Everyday Clinical PracticeCompletedNCT02240316
- Local, Non-Interventional Study of RoActemra (Tocilizumab) in Poland (ACT-POL): First-Line Treatment in Routine Clinical Practice of Participants With Rheumatoid Arthritis (RA)CompletedNCT02234960
- A Safety and Pharmacology Study of Atezolizumab (MPDL3280A) Administered With Obinutuzumab or Tazemetostat in Participants With Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell LymphomaCompletedNCT02220842Phase 1
- A Study to Assess Safety and Pharmacokinetics of MOXR0916 in Participants With Locally Advanced or Metastatic Solid TumorsCompletedNCT02219724Phase 1
- A Phase 1, Randomized, Double-blind, Placebo-controlled Crossover Study of RG7314 on the Potential Regulation of Higher Brain Functions in Healthy Male Participants: Proof of MechanismCompletedNCT02205073Phase 1
- A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous HistologyTerminatedNCT02204345Phase 1/2
- An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B StudyCompletedNCT02201407
- Effectiveness, Safety & Nurse Management Study of MabThera SC in Patients With Non-Hodgkin's Lymphoma: Real-Life SettingCompletedNCT02199288
- A Phase 1 Study of RO6806127 in Healthy Male VolunteersCompletedNCT02196636Phase 1
- Comparative Bioavailability Study of Film-coated Tablet and Granule Formulations of RG1662CompletedNCT02194244Phase 1
- A Study to Investigate the Tolerability of Subcutaneous (SC) Trastuzumab Administration in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Early Breast Cancer (eBC) Using Either a Single-Use Injection Device or Manual AdministrationCompletedNCT02194166Phase 3
- Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) ParticipantsCompletedNCT02187627Phase 1
- A Single-center Study to Investigate How Quickly and to What Extent a Radioactive Dose of RO5285119 is Absorbed, Metabolized and Eliminated From the Body of Healthy Male VolunteersCompletedNCT02179866Phase 1
- A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid TumorsCompletedNCT02174172Phase 1
- A Study of Oral Vismodegib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)WithdrawnNCT02168530Phase 2